CN110178035B - 2型糖尿病标志物及其用途 - Google Patents

2型糖尿病标志物及其用途 Download PDF

Info

Publication number
CN110178035B
CN110178035B CN201780083287.0A CN201780083287A CN110178035B CN 110178035 B CN110178035 B CN 110178035B CN 201780083287 A CN201780083287 A CN 201780083287A CN 110178035 B CN110178035 B CN 110178035B
Authority
CN
China
Prior art keywords
lysopc
diabetes
type
acid
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201780083287.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN110178035A (zh
Inventor
钟焕姿
方超
李俊桦
任华慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGI Shenzhen Co Ltd
Original Assignee
BGI Shenzhen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BGI Shenzhen Co Ltd filed Critical BGI Shenzhen Co Ltd
Publication of CN110178035A publication Critical patent/CN110178035A/zh
Application granted granted Critical
Publication of CN110178035B publication Critical patent/CN110178035B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/64—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for specific business sectors, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Social work
CN201780083287.0A 2017-04-18 2017-04-18 2型糖尿病标志物及其用途 Active CN110178035B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2017/080954 WO2018191866A1 (fr) 2017-04-18 2017-04-18 Marqueur du diabète de type 2 et utilisation associée

Publications (2)

Publication Number Publication Date
CN110178035A CN110178035A (zh) 2019-08-27
CN110178035B true CN110178035B (zh) 2022-09-23

Family

ID=63856367

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780083287.0A Active CN110178035B (zh) 2017-04-18 2017-04-18 2型糖尿病标志物及其用途

Country Status (2)

Country Link
CN (1) CN110178035B (fr)
WO (1) WO2018191866A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2595889A (en) 2020-06-10 2021-12-15 Daimler Ag Methods and systems for displaying visual content on a motor vehicle and method for providing a motor vehicle
CN112730638B (zh) * 2020-11-25 2022-07-29 首都医科大学附属北京朝阳医院 糖尿病合并心梗代谢标志物、检测试剂及试剂盒
CN114354827A (zh) * 2022-03-21 2022-04-15 天津云检医疗器械有限公司 代谢标志物及其在制备2型糖尿病的风险预测试剂盒中的应用和试剂盒
CN115266972A (zh) * 2022-07-19 2022-11-01 四川格林豪斯生物科技有限公司 组合标志物及筛选方法、诊断试剂或者试剂盒及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094200A2 (fr) * 2003-06-20 2005-10-13 University Of Florida Biomarqueurs permettant de differencier des diabetes de types 1 et 2
CN201438187U (zh) * 2009-07-28 2010-04-14 北京怡成生物电子技术有限公司 一种糖尿病检测分析装置
US9546994B2 (en) * 2012-08-13 2017-01-17 Helmholtz Zentrum Munchen-Deutsches Forschungszentrum fur Geseundheit und Umwelt (GmbH) Biomarkers for type 2 diabetes
ES2825105T3 (es) * 2014-04-08 2021-05-14 Metabolon Inc Obtención del perfil bioquímico de moléculas pequeñas de sujetos individuales para el diagnóstico de enfermedad y evaluación de la salud
CN105096225B (zh) * 2014-05-13 2019-10-22 深圳华大生命科学研究院 辅助疾病诊疗的分析系统、装置及方法
KR20170002318A (ko) * 2015-06-29 2017-01-06 고려대학교 산학협력단 대사체 분석을 이용한 당뇨병 조기 진단용 조성물
CN105166085A (zh) * 2015-07-08 2015-12-23 蚌埠市江淮粮油有限公司 一种抗氧化保健米糠油及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Characterization of D-3-hydroxybutyrylcarnitine (ketocarnitine): an identified ketosis-induced metabolite;Maarten R Soeters等;《Metabolism.》;20120630;第61卷(第7期);第966-973页 *

Also Published As

Publication number Publication date
CN110178035A (zh) 2019-08-27
WO2018191866A1 (fr) 2018-10-25

Similar Documents

Publication Publication Date Title
US10330688B2 (en) Metabolic biomarkers of autism
EP1922325B1 (fr) Méthodes permettant de diagnostiquer la démence et autres troubles neurologiques
CN110178035B (zh) 2型糖尿病标志物及其用途
US11181530B2 (en) Mass spectrometry method for detection and quantitation of metabolites
CN112798771B (zh) 用于诊断脑白质病变的生物标志物及其应用
Ferreira et al. Chemical profiling of cerebrospinal fluid by multiple reaction monitoring mass spectrometry
CN112798727B (zh) 用于诊断脑白质病变的生物标志物f7及其应用
US20150090010A1 (en) Method for diagnosing heart failure
CN112305121B (zh) 代谢标志物在动脉粥样硬化性脑梗死中的应用
CN109946411B (zh) 用于胸椎黄韧带骨化诊断的生物标记物及其筛选方法
Chen et al. Targeting amine-and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers
CN114236019B (zh) 脑白质病变的生物标志物的应用
CN109946467B (zh) 一种用于胸椎黄韧带骨化诊断的生物标记物
Zhao et al. Alteration of plasma metabolic profile and physical performance combined with metabolites is more sensitive to early screening for mild cognitive impairment
CN112305120B (zh) 代谢物在动脉粥样硬化性脑梗死中的应用
EP3203227B1 (fr) Composition de biomarqueur spécifique d'un patient atteint d'une maladie cardiaque chronique et son utilisation
CN113552227A (zh) 一组用于诊断儿童哮喘病的联合标志物及其应用和检测试剂盒
CN115219727B (zh) 与库欣综合征诊断相关的代谢物
EP3373007A1 (fr) Biomarqueurs pour le diagnostic et la progression de la sclérose en plaques progressive primaire
CN114047281B (zh) 帕金森病的生物标志物的组合及其应用
CN114019079B (zh) 诊断帕金森病的生物标志物及其应用
WO2023285462A1 (fr) Marqueurs biologiques de la maladie d'alzheimer
CN114047263A (zh) 代谢标志物在制备用于诊断ais的检测试剂或检测物的用途及试剂盒
CN116678974A (zh) 一种阿尔茨海默症血浆代谢标志物的筛选方法、血浆代谢标志物及应用
CN112599240A (zh) 代谢物在脑梗死中的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant